Olah KS;Redman CW;Gee H.Management of severe,early preeclampsia:is conservative management justified.Eur J Obstet Gynecol Reprod Biol.1993.175-OLAH K S ,REDMAN C W , GEE H. Management of severe , early pre - eclampsia : is conservative management justified ? [J ] . Eur J Obstet Gynecol ...
2013. Prevention and management of severe preeclampsia/eclampsia in Afghanistan. BMC Pregnancy and Childbirth, Vol. 13, Pp. 186.Kim YM, Ansari N, Kols A, Tappis H, Currie S, Zainullah P, Bailey P, Roosmalen J, Stekelenburg J. Prevention and management of severe preeclampsia/eclampsia in...
摘要: Features of severe preeclampsia include severe proteinuric hypertension and symptoms of central nervous system dysfunction, hepatocellular injury, thrombocytopenia, oliguria, pulmonary oedema, cerebrovascular accident and severe intrauterine growth restriction.关键词:...
Preeclampsia affects two patients, the mother and the fetus. Traditionally, women with severe preeclampsia have been delivered without delay, regardless of fetal considerations. Although delivery is appropriate therapy for the mother, aggressive management with immediate delivery of a fetus remote from ter...
53. Expectant management of severe preeclampsia in a developing country: Maternal outcomes and perinatal survival53. Expectant management of severe preeclampsia in a developing country: Maternal outcomes and perinatal survivaldoi:10.1016/j.preghy.2018.08.058Back...
It utilized biomarkers such as PlGF and the sFlt-1 to PlGF ratio to predict the risk of severe preeclampsia in the later stages of pregnancy. While both scenarios share the objective of improving preeclampsia screening tests, first trimester screening needs integration and cost-effective application ...
1.Clinical analysis onexpectant treatmentin 87 cases of early onset severe preeclampsia;87例早发型重度子痫前期期待治疗的临床分析 2.Conclusions:The patients with PPROM more than 35 weeks should be treated withexpectant treatment,while those patients with PPROM less than 34 weeks should be treated with...
since undergone FDA clearance, is one example of this approach. It utilized biomarkers such as PlGF and the sFlt-1 to PlGF ratio to predict the risk of severe preeclampsia in the later stages of pregnancy. While both scenarios share the objective of improving preeclampsia screening tests, first...
摘要: Preeclampsia is unpredictible disease and still remains the leading couse of fetal and maternal mortality and morbidity. maternal and fetal outcome of severe preeclampsia, <defined by ACOG sriteria, remote from term is presented.关键词:...
Today the only effective “treatment” for preeclampsia is to deliver at the optimal time for both maternal and foetal well-being. Studies reported that severe preeclampsia can benefit from the expectant management including mild preeclampsia between 34